The need for reimbursement of AIT
Rhinology Future Debates 2018 - Brussels
Patients’ experience using AIT is different and for better understanding by payers, the pharmacoeconomic studies should be based on real-life studies showing how to improve work and school nativity because of the potential monetary value.
Panellists: Claus Bachert, Jean Bousquet, Mohamed Shamji, Walter Canonica, AIT patient representative.
Stay in touch for further news from EUFOREA!
🌐 Visit our website: http://bit.ly/3qTanpG
➡️ Follow us on Facebook: http://bit.ly/3cnNyFF
➡️ Follow us on LinkedIn: http://bit.ly/2OqtWsf
➡️ Follow us on Twitter: http://bit.ly/38wrrM7
📌 EUFOREA is an international non-profit organization forming an alliance of all stakeholders dedicated to reduce the prevalence and burden of allergies and airway diseases through the implementation of optimal patient care through education, research and advocacy.
--------------------------------------------------------------------------------------------------------------------------
Subscribe to our YouTube Channel for our latest videos within Allergies and Airway Diseases
http://bit.ly/3eMvc3E
--------------------------------------------------------------------------------------------------------------------------
Get in touch with EUFOREA team for any questions
http://bit.ly/2OtlIQp
#EUFOREA